• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Clinova - Strategic SWOT Analysis Review Product Image

Clinova - Strategic SWOT Analysis Review

  • Published: May 2011
  • 18 pages
  • GlobalData


  • Allergy Therapeutics plc
  • Amarin Corporation plc
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • GW Pharmaceuticals plc
  • MORE

Clinova - Strategic SWOT Analysis Review


Clinova is a pharmaceutical company with focus on developing, manufacturing, licensing and marketing a range of pharmaceutical products and medical devices. The important products marketed by the company include COVAFLU, Quash, and Stemaderm. The company manufactures Covaflu FFP2 disposable face masks and Covaflu FFP3 disposable face masks to prevent harmful particles from entering lungs, by acting as a filtering process. These masks are used as a precautionary measure to protect from HINI flu. The company is also involved in conducting world class research programs to improve novel therapeutic products. It has developed an extensive pipeline of potential new products through research programs. In addition, the company develops clinical-stage compounds in collaboration with external partners. Clinova is headquartered in Hampshire, the UK.

Our Clinova - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors READ MORE >

List of Tables
Section 1 - About the Company
Clinova - Key Facts
Clinova - Key Employees
Clinova - Key Employee Biographies
Clinova - Key Operational Employees
Clinova - Major Products and Services
Clinova - History
Clinova - Company Statement
Clinova - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Clinova - Business Description
Clinova - Corporate Strategy
Clinova - SWOT Analysis
SWOT Analysis - Overview
Clinova - Strengths
Strength - Global Presence
Strength - In-house Research Expertise
Clinova - Weaknesses
Weakness - Private Ownership
Clinova - Opportunities
Opportunity - Changing Demographics
Opportunity - Market Potential: Pain
Opportunity - Emerging Markets-Strong Growth Prospects
Opportunity - Strategic Agreements and Collaboration
Clinova - Threats
Threat - Government Regulations
Threat - Competitive Pressures
Threat - Uncertain R&D Outcomes
Clinova - Key Competitors
Section 3 – Appendix
About Us
Contact Us

Amarin Corporation plc
Allergy Therapeutics plc
GW Pharmaceuticals plc
GlaxoSmithKline plc
AstraZeneca PLC

Note: Product cover images may vary from those shown